We assessed the prevalence of strains of both families and the epidemiologic and clinical features of those infected with Beijing family strains.
INTRODUCTION
Multidrug-resistant tuberculosis (MDR TB) and extensively drug-resistant tuberculosis (XDR TB) represent a relevant public health concern.
1 In total, 9.6 million new tuberculosis (TB) cases were reported worldwide in 2014, 3 .3% of which presented with MDR TB, 20% of previously treated cases and 9.7% of MDR TB patients presented with XDR TB.
2 According with the Portuguese Direcção-Geral da Saúde, a 20.0/100,000 incidence rate of TB and a 2.5% prevalence rate of MDR TB was found in Portugal in 2014, considering those cases notified and tested in Portugal, from which 26% presented with XDR TB, particularly concentrated in the Lisbon and Tagus Valley region. Approximately 78% of MDR TB patients (n = 18) affected Portuguese patients and the remaining 22% (n = 5) affected patients from Eastern Europe (n = 1), Western Europe (n = 1), Africa (n = 2) and Asia (n = 1). 3 Beijing family has been the most studied strain family of Mycobacterium tuberculosis (M. tuberculosis) worldwide and was first described in 1995, when it was identified in the Beijing province (China) and in Mongolia, 4 later isolated in different neighbouring countries and currently corresponding to the predominant family in Asia, with a prevalence of 48% in Vietnam, 44% in Thailand, 70% in Hong-Kong and over 50% in many other countries as China and South Korea. [4] [5] [6] [7] [8] Ninety per cent of TB patients were infected by Beijing family strains in a study carried out in a Chinese province, 27% of which were multidrug-resistant (MDR) and, in Japan and in Taiwan, these represented 70% of XDR and 48% of MDR TB cases, respectively. [9] [10] [11] A high prevalence of Beijing family strains has also been found in Russia, where these were responsible by 48% of MDR TB cases and by active spread into the community. [12] [13] [14] [15] Beijing family strains were also found in the USA. 16, 17 W-Beijing family strains emerged in the nineties in New York and were responsible by major outbreaks in hospitals and in prisons, associated with human immunodeficiency virus (HIV) infection, showing multidrug-resistance, rapidly spreading and involving a difficult management. [16] [17] [18] A group of 267 patients were affected by these micro-organisms in four hospitals in New York and caused over 90% mortality, characterised by specific drug susceptibility testing (DST) pattern and laboratorial abnormalities. The genetic analysis of these strains found a recent transmission in 40% of the patients, contrasting with the concept of reactivation or the involvement of inadequate treatment. 16, 19, 20 More than 500 patients were described in New York between 1990 and 1995 and strains were transmitted to ten other NorthAmerican states, being responsible by more than 25% of MDR TB patients in the USA. 16, 21 In Europe, a Swedish study showed that only 13% of MDR strains were from the Beijing family and were mostly isolated in Asian immigrants, even though no transmission has been documented in this country, in Denmark or in Finland (where very low incidence rates were also found), despite the geographic proximity with Russia and the Baltic countries. 22 In Poland, these strains were exclusively found in 9% of MDR TB patients, suggesting that these have some responsibility in its community transmission. 23 Finally, a predominance of the Beijing family has been found in France between 2009 and 2010 (75%) among the MDR strains isolated from patients from Central and Eastern Europe and from Asia, including from French patients, even though with no epidemiological connection between patients.
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Beijing family strains are therefore spread all over the world and seem associated with multidrug-resistance. In Iran, 15 immunocompetent patients infected with Beijing and Harlem family strains of M. tuberculosis were found in 2009, showing resistance to all second-line anti-TB drugs,  having been called as totally drug-resistant tuberculosis  (TDR TB) . 25 An overwhelming worldwide distribution of this strain family has been found and its intrinsic characteristics and defining environmental or host factors remain unclear. Even though it has been already involved (such as the N strain family) in epidemics of drug-sensitive tuberculosis and in non-resistance associated clusters, an association with resistance to anti-TB drugs and generally inducing more severe forms of TB, higher therapeutic failure and higher number of relapsing cases, when compared to other families, has been found in many regions (Estonia, Germany, South Africa, Cuba) and whether the acquisition of multidrug-resistance is easier or there is more tendency for transmission remains unclear. 12, [26] [27] [28] [29] [30] [31] [32] [33] [34] In addition, strain virulence (defined by its ability to cause excessive morbidity and mortality) also remains unclear.
A predominant family, called Lisboa family, due to the presence of a genetically distinct genotype related to the Latin-American-Mediterranean (LAM) genotype, has also been identified in Portugal between 1992 and 1994, based on samples from 124 HIV co-infected and immunocompetent patients. 35 Since then, these strains have been identified over the years as highly prevalent in MDR TB and XDR TB patients found in the area. [36] [37] [38] [39] A 2010 study found that more than 50% of XDR TB patients in Lisbon were infected with this strain family and it remains predominant and spreading over more than 20 years, as found in a more recent study. 40, 41 At the same time, some studies have described the identification of Beijing family strains in MDR and XDR TB patients from Lisbon, with prevalence rates below 2.5%, even though no study has up to date characterised the patients infected with this family strain as regards epidemiology, clinical presentation and progression.
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Aims
This study aimed at the identification of the strains of M. tuberculosis isolated and genotyped from MDR and XDR TB patients attending a Lisbon hospital between 1993 and 2015, at the evaluation of Lisboa and Beijing family strains and the epidemiological and clinical characteristics of the latter, particularly as regards DST patterns as well as the outcome in MDR and XDR TB patients living in the Lisbon area.
MATERIAL AND METHODS
This was a retrospective study involving all MDR and -50 µg/mL and para-aminosalicylic acid (PAS) -0.5 µg/mL. INH (0.1 µg/mL), RMP (2 µg/mL), SM (2 µg/mL and 6 µg/ mL), EMB (2.5 µg/mL and 7.5 µg/mL), pyrazinamide (PZA) -100 µg/ml, capreomycin (CM) -1.25 µg/mL), amikacin (AM) -1.0 µg/mL, kanamycin (KM) -5.0 µg/mL, ofloxacin (OFX) -2.0 µg/mL, sparfloxacin (SFX) -0.4 µg/mL, rifabutin (RFB) -0.5 µg/mL, ETO (1.25 µg/mL), clofazimine (CFZ) -0.5 µg/mL, PAS (4.0 µg/mL) and ciprofloxacin (CFX) -0.5 µg/mL and 1.0 µg/mL with Bactec 460 TB liquid medium. INH (0.1 µg/mL), RMP (1.0 µg/mL), SM (1.0 µg/mL), EMB (5 µg/mL), PZA (100 µg/mL), ETO (5.0 µg/mL), OFX (2.0 µg/mL), CM (1.25 µg/mL), AM (1.0 µg/mL), linezolid (LZD) -1.0 µg/mL and moxifloxacin (MFX) -0.25 µg/mL were used with Bactec MGIT 960 liquid medium. Multidrug-resistant tuberculosis was defined as the presence of resistance to at least INH and to RMP and XDR TB as multidrugresistant tuberculosis with the addition of resistance to any fluoroquinolone and to any injectable second-line anti-TB drug (CM, KM and AM). TDR TB was also considered with the presence of in vitro resistance to all first and second-line anti-TB drugs tested. 44 Primary resistance or among new TB cases was defined as the presence of resistance to one or more anti-TB drugs in patients who were not previously exposed to these drugs. 45 Acquired resistance or among previously treated patients (or secondary resistance) was defined as the presence of resistance to one of more anti-TB drugs, related to inadequate or insufficient therapy due to poor adherence to treatment, poor drug absorption or wrong prescription. 45 Strain typification (molecular identification) was obtained up to 2002 by using the restriction fragment length polymorphism technique, followed by hybridization with the sequence of insertion 6110 (RFLP-IS6110) and from 2013 onwards by using the mycobacterial interspersed repetitive units-variable number of tandem repeats (MIRU-VNTR) technique and finally, since 2009, also by spacer oligonucleotide typing (Spoligotyping). [46] [47] [48] A cluster was defined as the presence of two or more isolates with RFLP-IS6110 patterns and differing by one or two bands or as the presence of two or more isolates with similar MIRU-VNTR profiles. A family was defined as a group of isolates showing over 90% homology.
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Patients were considered cured when, upon treatment completion (at least 18 or 24 months upon the last positive culture), symptoms remitted (clinical cure) and M. tuberculosis was no longer identified in the same specimen as it was previously isolated (microbiological cure). TBrelated death was considered when no clinical and / or microbiological cure was found at the moment when it happened.
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RESULTS
In total, 104 patients with an available MDR or XDR M. tuberculosis genetic strain characterisation, living in the Lisbon area, were included in the study. No more than one genotyping or genotyping from different specimens per patient was available.
Seventy-four (71.2%) out of 104 strains that were isolated from our group of patients were included into two predominant clusters already identified in the nineties as being infected with Lisboa family strains, mainly affecting HIV co-infected patients, drug users and poorly adherent patients to medication for previous TB episodes (with no DST pattern of resistance to anti-TB drugs). In addition, 5 Beijing family strains (4.8%) and 25 different strains (24.0%) that were called as 'other' due to the presence of individually unique genotypic patterns were found. Very different polymorphisms were found among strains, with the predominance of Lisboa family strains that were always found in this study between 1993 and 2015, while Beijing family strains were only found from 2009 onwards ( Table 1) .
Characterisation of the patients infected with Beijing family strains
As regards patient no.1, the strain was isolated in sputum culture from a male, Caucasian, 56-year-old, immunocompetent patient from Angola temporarily living in Lisbon, with a history of anti-TB drug sensitive pulmonary TB (documented in Luanda two years before), poorly adherent to treatment and presenting with MDR pulmonary TB. Symptoms started 60 days earlier and chest XR and CT scan showed a diffuse bilateral nodular interstitial infiltrate involving the entire lung fields, with bilateral cavitations located at the upper zones and the apices. Sensitivity tests to first and second line anti-TB drugs showed resistance to INH, RMP and ETO. This strain was not found in any other biological specimen and the patient was treated according with the drug susceptibility testing (DST) and was cured. As regards patient no. 2, the strain was isolated in sputum culture from a male, Caucasian, 35-year-old patient from Ukraine, living in Lisbon for 10 years, hepatitis C virus (HCV) / HIV co-infected, injection drug user (IDU), with no previous TB history and no contact with TB patients or with miliary TB patients. TB infection revealed the underlying immunodeficiency and showed a CD4 + T-lymphocyte count of 62 cells/µL. Symptoms started 120 days earlier and the patient did not seek medical care. Chest imaging showed a micronodular miliary pattern, with liver and splenic micronodules and also with choroidal tubercles on fundoscopy. The strain of M. tuberculosis was identified from pulmonary specimens and DST showed resistance to INH, RMP, EMB, SM, PZA, ETO, KM and AM. Even though treated with anti-TB and antiretroviral drugs, cultures did not negativize and the patient died due to TB 87 days upon therapy was started.
As regards patient no. 3, the strain was isolated from a female, Caucasian, 38-year-old, immunocompetent patient from Ukraine, living in Lisbon for 10 years and with no previous TB history. The patient described a contact with her brother who had died three years before in Ukraine due to MDR TB and who had visited her in Lisbon. Thirty days upon onset of symptoms, the patient was diagnosed with cavitating pulmonary TB, showing alveolar condensation and nodular infiltrate at the upper lobes and apical zone of the right lung. AFB were identified in direct sputum smear microscopy and in culture; DST showed resistance to INH, RMP, EMB, SM, PZA, ETO and AM. Anti-TB drugs were started and the patient showed good adherence to treatment; 29 days later, direct smear was negative and culture was negative two months upon treatment was started and the patient progressed towards the cure.
As regards patient no. 4, the strain was isolated from a female, Caucasian, 32-year-old, immunocompetent patient born in Lisbon, where she had always lived and with no previous TB history. Around 60 days upon onset of symptoms, she was diagnosed with cavitating pulmonary TB, showing condensation and nodular infiltrate of the middle and the lower lobe of the right lung. Diagnosis was based on the DST pattern that showed resistance to INH, RMP, EMB, SM and ETO. Upon therapy, cultures were Table 1 negative and the patient progressed towards the cure. As regards patient no. 5, the strain was isolated from a male, Caucasian, 36-year-old, immunocompetent patient living in Lisbon, brother of patient no. 4, with no previous TB history, with a negative tuberculin skin test obtained three months earlier. Twenty one days upon onset of symptoms, the patient was diagnosed with cavitating pulmonary TB, showing a nodular infiltrate and condensation affecting the upper lobes and apices of both lungs. This strain of M. tuberculosis showed an overlapping DST with her sister's. Upon therapy, microscopy was negative at D28 and culture at two months and the patient progressed towards the cure.
The five Beijing family strains found in this study regarded one patient from Angola, two patients from Ukraine and two Portuguese patients, all living in Lisbon and aged 32-38, except patient no. 1 ( Table 2 ). Patient no. 1 had been previously diagnosed in Angola with drug-sensitive TB, had been poorly adherent to treatment and therefore suggesting the presence of a sequential resistance accumulation, i.e. acquired MDR TB and strain importation to Portugal. Both patients from Ukraine, living in Lisbon for 10 years, with no previous TB history, suggested the presence of primary MDR TB. AS regards HIV co-infected patient no. 2, no contacts were known with other TB patients and the reactivation of the strain of M. tuberculosis from Ukraine could not be ruled out; the fact that MDR TB emerged at an advanced stage of immunosuppression may suggest the presence of a recent transmission. On the contrary, a recent contact had been described by patient no.3 with her brother who had died in Ukraine from MDR TB and who may have introduced a Beijing family strain in Lisbon. As regards patient no. 4 and 5, these were siblings living at the same house, with no previous TB history and who had not travelled abroad, who were infected with two strains with an overlapping resistance phenotype, also suggesting the presence of primary MDR TB and a recent transmission. In fact, patient no. 5 had a negative tuberculin skin test three months before diagnosis.
Apart from those described, no other epidemiological connections were found between these five patients.
Clinical manifestations and imaging were in line with the conventional TB clinical presentation and no particular detail had been found; the TB dissemination or the absence of pulmonary cavitation in HIV/HCV co-infected patient (patient no. 2) were not surprising. Apart from this patient, who presented with miliary TB, all the remaining were immunocompetent patients and presented with cavitating pulmonary TB and no extra-pulmonary involvement (Table  3 ) and all sought medical attention at an earlier stage (HIV co-infected patient only sought medical attention upon onset of symptoms).
Direct sputum smear microscopy was positive in the first specimen tested in immunocompetent patients, allowing for a DST and immediate treatment for MDR TB. Diagnosis was only obtained at an advanced stage of the disease in patient no. 2, showing a CD4 + T-lymphocyte count of 62 cells/µL and repeated direct sputum smear was only positive 12 days upon admission, leading to a late start therapy for MDR TB. Multidrug-resistance was confirmed by culture in the five patients and no XDR or TDR TB was found (Table 4) . In immunocompetent patients, the identification of bacilli in direct microscopy or isolated in culture exclusively occurred in sputum, even though other biological specimens were tested. DST patterns found in specimens of the five patients were different from patient to patient, except regarding patient no. 4 and 5. All immunocompetent patients were cured.
DISCUSSION
Lisboa family strains of M. tuberculosis were mostly found in MDR and XDR TB patients living in the Lisbon area (71.2% of 104 strains), in line with other studies. 36, 40, 41 Only 4.8 % (n = 5) Beijing family strains were found from 2009 onwards. Even though the evaluation of the prevalence of this strain family in MDR and XDR TB patients living in the Lisbon area was not the primary aim of the study, its relevance in the epidemics is in fact higher, considering the identification of these strains in this region since 1999 and the prevalence rates already found in other studies [41] [42] [43] as well as considering the fact that spoligotyping technique has been regularly used from 2009 onwards. This method was for the first time introduced in 1997 and, even though it has a lower discrimination ability when compared to RFLP-IS6110 and MIRU-VNTR typing, it is particularly useful for the identification of Beijing, LAM, Harlem, CAS strain families as well as other strains and lineages of M. tuberculosis and has emerged as a quick, sensitive and cost-effective alternative method that can be directly used on the specimen, with no culture. 48, 50 The epidemiological and clinical characterisation of our group of patients (a small group of patients infected with Beijing family strains) showed that these strains were mainly found in young immunocompetent patients with no previous TB history, no comorbidities, suggesting the presence of primary TB and acquired from recent transmission. A study carried out in Vietnam showed that 71% of the patients infected by Beijing family strains (54 out of 76) were aged under 25, leading to the conclusion that transmission had been recent. 7 Other studies involving a more significant number of patients have found that strains from this family had some prominence in the active transmission into the community and in primary TB. 10, 11, 15, 23 In addition, what may have happened with these strains in the Lisbon area remains unclear, namely over the first years of MDR TB epidemics, in which HIV co-infected patients, IDUs, patients with MDR TB secondary to poor adherence to treatment and Lisboa family strains were predominant. 36, 38 No clinical manifestations or radiological signs related to Beijing family strains were found regarding any of the five patients in this study, in immunocompetent patients as in the HIV co-infected patient, all with pulmonary TB; however, the frequent presence of cavitation should be mentioned. Other studies involving larger samples also did not show any relation between the infection with Beijing family strains and any specific clinical manifestation or radiological abnormality, including the presence of cavitation; a febrile response to treatment was the only association found.
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All the patients presented with pulmonary TB and bacilli were only found in direct microscopy and in culture using specimens collected from the respiratory tree (negative in gastric juice, urine and blood in immunocompetent patients and also in cerebrospinal fluid in the HIV co-infected patient). A concomitant extra-pulmonary involvement was only found in the HIV co-infected patient, enabled by immunosuppression. Extra-pulmonary TB usually occurs in 10-42% of TB patients, depending on patient's ethnicity, presence or absence of any underlying disease as well as on patient's immune status, but also on the genotype of M. tuberculosis strain. 53 The association of Beijing family strains with a small number of cases of extra-pulmonary TB cannot be established from our small group of patients as well as whether this stems from any intrinsic factors and from lower bacterial aggressivity or from the fact that it mostly affect immunocompetent patients. The pattern of resistance was different in patients infected by Beijing family strains and none of the patients presented with XDR or TDR TB. As described in other studies, no correlation may be established between genetic patterns and drug resistance phenotypes, as these may vary depending on the isolation timing and the DST technique, even though we did not find any predominant pattern, which does not allow for the determination of whether these strains have been accumulating resistances or have been spreading into the community, due to the dimension of our sample. 36, 38 Some studies showed that Beijing family strains, when compared to others, are usually associated with more severe lung abnormalities, with pneumonia and death and also with a weaker immune response. 54 A more recent study showed that Beijing family strains were a risk factor for therapeutic failure and relapse, regardless of the identification of drug resistance. 55 Different studies have also shown that these strains are associated with the induction of more severe forms of TB and with more therapeutic failures, when compared to other strain families. 12, 29, 56 On the contrary, a higher cure rate has been found in this study (four out of five patients). All immunocompetent patients were cured, even though an early diagnosis may have contributed to the outcome, due to the subsequent availability of molecular drug resistance testing, allowing for more timely treatment. Upon therapy was started, not only high rates of cure were obtained as also direct sputum microscopy quickly became negative, patients remained smear-positive for a short time and the risk of transmission was prevented. The only deceased patient, HIV co-infected and presenting with an advancedstage disease, only sought medical attention 120 days upon onset of symptoms. When confirmed by studying a larger number of patients, cure rates will certainly improve, even above those found in other regions of the world involving other MDR strains of M. tuberculosis in the eighties and in the nineties, which were characterised by high mortality and quick progression, such as W-Beijing family strains in the USA or Lisboa family strains in Portugal. 16, 17, 21, 37, 38, 57 Prevalence rates of 44.7, 27.9, 12.5 and 8.9% have been found with Beijing family strains in Asia, Europe, Africa and in America, respectively and 81.6% of the strains were associated with resistance (with higher rates in China and in Russia). 4, 5, 58 Molecular genotyping methods have an important role in understanding transmission pathways and worldwide distribution of MDR and XDR TB and allow for the conclusion that there is a strong association between patient's country of origin and MDR family isolates. 24 Patient no.1 was infected by a Beijing family strain found in a patient from Angola that was imported from this country. The second and the third strain affected patients from Ukraine and may have been imported or may have been recently transmitted in Lisbon, while the remaining two strains affected Portuguese patients and were acquired from a transmission in Lisbon. The fact that most were immunocompetent, young patients, with no previous TB history, with no risk factors (alcohol addiction or homeless patients, for instance) and no comorbidities may suggest a high level of potential transmission of these strains into the community.
In addition, even though there is no evidence of any widespread transmission of Beijing family strains in Portugal (shown by epidemiological or genotypic studies), these patients show that strains from other geographical regions regularly or irregularly invaded the Portuguese territory and may spread and become prevalent and even aggravate TB clinical progression and outcome in Portugal, which shows some epidemiological instability. It should be reminded that Lisbon is a reference for the immigration of patients from regions where MDR TB and Beijing family strains are highly prevalent, such as Sub-saharan Africa or Eastern Europe. 59 Beijing family strains only corresponded to 4.8% of the strains found in the study (five patients, 2009 to 2015), showing a periodical introduction of strains imported from other geographical regions into the Lisbon area. Even though currently with lower epidemiological relevance, these strains spread into the community and may aggravate or impair the control of the epidemics or even become predominant. There is an evidence of their transmission into the community, even though we still may not determine that resistances have been accumulating. Beijing family strains already represented 11% of all the isolates tested worldwide in 2002 and, considering their association with MDR, its prevalence in certain regions of the world and globalisation, they may become a serious concern for TB control in Portugal, if uncontrolled. 60 The small number of Beijing family strains identified is the greater limitation to this study, making its epidemiological and clinical characterisation more difficult. Even so, the results suggest the presence of particular characteristics that contrast with the rate of therapeutic failure described with these and other strains in other regions and that may correspond to different virulence, namely with lower bacterial aggressivity, lower mortality, better cure rates and better outcome when compared to W-Beijing family or Lisboa family strains. This is the first study aimed at the evaluation of patients living in Lisbon and infected with MDR Beijing family strains of M. tuberculosis. Molecular research should be extended, in conjunction with epidemiology and clinical research, in order to improve the detection and control ability of transmission pathways of this family strains and to optimize sensitivity and early diagnosis, as a contribution for outcome improvement.
